Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

BACKGROUND: The prognostic impact of increased beta-2 microglobulin (B2M) in patients with light chain (AL) amyloidosis undergoing autologous stem cell transplantation (ASCT) is unknown. The Mayo 2012 stage and increased bone marrow plasma cell (BMPC) percentage are known predictors for survival. In...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Al Saleh, Abdullah S., Sidiqi, M Hasib, Muchtar, Eli, Buadi, Francis K., Dispenzieri, Angela, Warsame, Rahma, Lacy, Martha Q., Dingli, David, Gonsalves, Wilson I., Kourelis, Taxiarchis V., Hogan, William J., Hayman, Suzanne R., Kapoor, Prashant, Kumar, Shaji K., Gertz, Morie A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7371505/
https://ncbi.nlm.nih.gov/pubmed/32422250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.04.024
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi